Clinical Trial Update: B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for B-pVAC-SARS-CoV-2 evaluating prevention of COVID-19 infection in adults with B-cell/antibody deficiency; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Deficiency Disease

Drugs mentioned

• B-pVAC-SARS-CoV-2

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Immune Deficiency Disease | Phase 1, Phase 2 | Status: COMPLETED